Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes

Journal of Autoimmunity

Volumn 25, Issue 1, 2005, Pages 21-32

  Preda Pais, Anca ^a   Stan, Alexandru C ^b   Casares, Sofia ^c   Bona, Constantin ^c   Brumeanu, Teodor D ^a  

^a Uniformed Services University of the Health Sciences   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune diabetes; CD4 T cells; Clonal deletion; MHC II peptide chimeras

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CELL MEMBRANE; CHIMERA; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE DELETION; IMMUNITY; IMMUNOPHARMACOLOGY; LIPID RAFT; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL MEMBRANE; CELLS, CULTURED; CLONAL ANERGY; CLONAL DELETION; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS CLASS II; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; PREDIABETIC STATE; RATS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; THYMUS GLAND;

EID: 22444443107     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2005.04.003     Document Type: Article

References (24)

1. R. Tisch, and H.O. McDevitt Insulin-dependent diabetes mellitus Cell 85 1996 291 297
2. G.T. Nepom, and H. Erlich MHC class-II molecules and autoimmunity Annu Rev Immunol 9 1991 493 525
3. J.D. Katz, C. Benoist, and D. Mathis T helper cell subsets in insulin-dependent diabetes Science 268 1995 1185 1188
4. J.D. Peterson, B. Pike, M. McDuffie, and K. Haskins Islet-specific T cell clones transfer diabetes to non-obese diabetic (NOD) Fl mice J Immunol 153 1994 2800 2806
5. L.S. Wicker, B.J. Miller, and Y. Muller Transfer of autoimmune diabetes mellitus with splenocytes from non-obese diabetic (NOD) mice Diabetes 35 1986 855 860
6. J.F. Bach Immunotherapy of insulin-dependant diabetes mellitus Curr Opin Immunol 13 2001 601 605
7. D. Elias, and I.R. Cohen Peptide therapy for diabetes in NOD mice Lancet 343 1994 704 706
8. S. Casares, C. Bona, and T.-D. Brumeanu Enzymatically mediated engineering of multivalent MHC II-peptide chimeras Protein Eng 14 2001 195 200
9. S. Casares, C.S. Zong, D.L. Radu, A. Miller, C.A. Bona, and T.-D. Brumeanu Antigen-specific signaling by a soluble, dimeric peptide/MHC class II/Fc chimera leading to Th2 differentiation J Exp Med 190 1999 543 553
10. S. Thomas, A. Preda-Pais, R.S. Kumar, S. Casares, and T.-D. Brumeanu A model for antigen-specific T cell anergy: displacement of CD4-p561ck signalosome from the lipid rafts by a soluble, dimeric peptide-MHC II chimera J Immunol 170 2003 5981 5992
11. S. Casares, A. Hurtado, R.C. McEvoy, A. Sarukhan, H. von Boehmer, and T.-D. Brumeanu Downregulation of diabetogenic T-cells by a soluble MHC II-peptide chimera Nat Immunol 3 2002 383 391
12. S. Weber, A. Trannecker, F. Olivery, W.V. Gerahrd, and K. Karjalainen Specific low-affinity recognition of MHC complex plus peptide by soluble T-cell receptor Nature 356 1992 793 796
13. S. Casares, C.A. Bona, and T.-D. Brumeanu Engineering and characterization of a murine MHC class II-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope Protein Eng 10 1997 1295 1301
14. M. Muzio, A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, and J. Ni FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817 827
15. S. Thomas, R.S. Kumar, S. Casares, and T.-D. Brumeanu Sensitive detection of GM1 sphingolipid and TCR partitioning in T-cell membrane J Immunol Methods 275 2003 161 168
16. S.T. Ju, D.J. Panka, H. Cui, R. Ettinger, M.E. Khatib, and D.H. Sherr Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation Nature 373 1995 444 448
17. E.E. Varfolomeev, M. Schuchmann, V. Luria, N. Chiannilkulchai, J.S. Beckmann, and I.L. Mett Targeted disruption of the mouse caspase 8 gene ablates cell death induction by TNF receptors, Fas/Apol, and DR3 and is lethal prenatally Immunity 9 1998 267 276
18. H. Grassme, A. Jekle, A. Riehle, H. Schwarz, J. Berger, and K. Sandhoff CD95 signaling via ceramide-rich membrane rafts J Biol Chem 276 2001 20589 20596
19. D. Scheel-Toellner, K. Wang, R. Singh, S. Majeed, K. Raza, and S.J. Curnow The death-inducing signaling complex is recruited to lipid rafts in Fas-induced apoptosis Biochem Biophys Res Commun 297 2002 876 879
20. T. Garofalo, R. Misasi, V. Mattei, A.M. Giammarioli, W. Malorni, and G.M. Pontieri Association of the death-inducing signaling complex with microdomains after triggering through CD95/Fas: evidence for caspase 8-ganglioside interaction in T cells J Biol Chem 278 2003 8309 8315
21. L.K. Clayton, Y. Ghendler, E. Mizoguchi, R.J. Patch, T.D. Ocain, and K. Orth T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection EMBO J 16 1997 2282 2293
22. Z. Reich, J.J. Boniface, D.S. Lyons, N. Borachov, E.J. Watchel, and M.M. Davis Ligand-specific oligomerization of T-cell receptor molecules Nature 387 1997 617 620
23. S. Thomas, A. Preda-Pais, S. Casares, and T.-D. Brumeanu Analysis of lipid rafts in T-cells Mol Immunol 41 2004 399 409
24. V. de Mello Coelho, D. Nguyen, B. Giri, A. Bunbury, E. Scaffer, and D.D. Taub Quantitative differences in lipid rafts components between murine CD4+ and CD8+ T cells BMC Immunol 5 2004 1 8